LOUISVILLE, Ky., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring

BrightSpring Health Services is expanding AI and automation across its operations, with early margin

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

BrightSpring's faster growth, pharmacy and provider-service expansion, and improving margins contras

BrightSpring Health Services (NASDAQ: BTSG) outlined its growth strategy across pharmacy and provide

BrightSpring Health Services NASDAQ: BTSG outlined its growth strategy across pharmacy and provider

BTSG's stronger cash flow and lower leverage could give it more flexibility to pursue acquisitions a

RDVT, BTSG and THC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 24th,

Centene, BrightSpring and Delek combine 52-week gains with short-term pullbacks, putting them in foc

BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology a

BrightSpring Health Services, Inc. (BTSG) Presents at Morgan Stanley 24th Annual Global Healthcare C

BTSG's specialty pharmacy, infusion and home-based care expansion support growth, while IRA and exec

BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, b

BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launc

BrightSpring Health Services is rated buy, driven by rapid profitability growth, expanding Provider

BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-1

NVDA's 63.7% net profit margin and 93.3% expected earnings growth put it among three profitable stoc

Shares of BrightSpring Health Services, Inc. (NASDAQ: BTSG - Get Free Report) have been assigned an

William Blair reshuffled its September stock picks, bringing eight companies onto its Analyst Convic

Canada Pension Plan Investment Board purchased a new position in BrightSpring Health Services, Inc.

The Benzinga Stock Whisper Index highlights five unique stocks each week that attract high reader an

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $

BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the anal

BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $14.725 billion-$15.225 billion t

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260714-1484349/1484349_gtls46.

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

Keybanc analyst Matthew Gillmor maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

Guggenheim analyst Jason Cassorla initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a

Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Consider

Raymond James analyst Parker Snure initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a

UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price

B of A Securities analyst Kevin Fischbeck maintains BrightSpring Health (NASDAQ:BTSG) with a Buy

Top Wall Street analysts changed outlook on top names. See all changes, including upgrades/downgrade

BTIG analyst David Larsen maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the p

TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises

Goldman Sachs analyst Scott Fidel initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a

BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"),

BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"),

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises

BrightSpring Health Services (BTSG) reported strong Q1 results with increased full-year guidance. An

Keybanc analyst Matthew Gillmor maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and

Stephens & Co. analyst Raj Kumar maintains BrightSpring Health (NASDAQ:BTSG) with a Overweig

BMO Capital analyst Sean Dodge maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and

Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday.